×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Safety in Special Situations: Stem Cells, Vaccines, and Combination Products
Session Chair(s)
Arpad Simon, MD
VP Drug Safety and Pharmcovigilance
Relypsa, United States
This symposium will provide insights and guidance for signal detection and analysis of vaccines along with the challenges of having disproportionally-based signal detection methodologies. It will also include some of the factors to consider for stem cells and regenerative medicine and combination products.
Learning Objective : Discuss vaccine pharmacovigilance; Explain pharmacovigilance in special situations such as stem cells and combination products; Identify challenges of disproportionally- based signal detection methodologies in special situations.
Speaker(s)
Safety and Stem Cells
Arpad Simon, MD
Relypsa, United States
VP Drug Safety and Pharmcovigilance
Requirements, Potential Approaches, and Challenges in Pharmacovigilance and Risk Management Practices for Combination Products
Ajay Keshava, MS
WCI Consulting, United States
Managing Consultant
Have an account?